Thomson Reuters
TRI
101.56
+1.02
+1.01%
Thomson Reuters
US · TRI
#530 by market cap
Listed 1970
101.56
+1.02
+1.01%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
BMO Capital Maintains Thomson Reuters(TRI.US) With Buy Rating, Raises Target Price to $120Market Newswire · 2026/9/15
-
Rating change
Barclays Maintains Thomson Reuters(TRI.US) With Buy Rating, Cuts Target Price to $130Market Newswire · 2026/9/9
-
Rating change
TD Cowen Maintains Thomson Reuters(TRI.US) With Buy Rating, Cuts Target Price to $143.8Market Newswire · 2026/9/15
-
Rating change
Barclays Maintains Thomson Reuters(TRI.US) With Buy Rating, Maintains Target Price $130Market Newswire · 2026/10/2
-
Rating change
TD Cowen Maintains Thomson Reuters(TRI.US) With Buy Rating, Cuts Target Price to $141.75Market Newswire · 2026/9/24
-
Rating change
Wells Fargo Maintains Thomson Reuters(TRI.US) With Hold Rating, Maintains Target Price $100Market Newswire · 2026/9/23
-
Rating change
Tri Chemical Laboratories Inc. (4369) Gets a Buy From Morgan StanleyTipRanks · 2026/9/28
-
Form 144 | Thomson Reuters(TRI.US) 10% Stockholder Proposes to Sell 217.66 Million in Common StocksMarket Newswire · 2026/11/12
-
Company notice
Icom: Notice Regarding a Strategic Capital and Business Alliance Involving the Joint Venture Formation of LIMNO Co., Ltd. Between TRI-IDEAS Co., Ltd. and ICOM Co., Ltd.JPX · 2026/10/30
-
Company notice
TriIs: Notice Regarding a Strategic Capital and Business Alliance Involving the Joint Venture Establishment of LIMNO Co., Ltd. Between TRI-IDEAS Co., Ltd. and ICOM Co., Ltd.JPX · 2026/10/30
-
Morgan Stanley Maintains Thomson Reuters(TRI.US) With Hold Rating, Cuts Target Price to $115Market Newswire · 2026/11/5
-
Rating change
BMO Capital Maintains Thomson Reuters(TRI.US) With Buy Rating, Raises Target Price to $130.43Market Newswire · 2026/11/4
-
BofA Securities Maintains Thomson Reuters(TRI.US) With Hold Rating, Raises Target Price to $125Market Newswire · 2026/11/5
-
Company notice
TriIs: Notice Regarding the Appointment of an Executive Officer at TRI-IDEAS Co., Ltd. — Strengthening the PMI Framework to Enhance Corporate Value Post-M&A —JPX · 2026/10/1
-
Company notice
Tri Chemical Laboratories: Report on Large-Scale Shareholdings (Securities Subject to Special Treatment, etc.)EDINET · 2026/10/22
-
TRI CONTINENTAL CORP USD2.50 CUM PFD USD50 To Go Ex-Dividend On December 14th, 2026 With 0.625 USD Dividend Per ShareMarket Newswire · 2026/11/20
-
Rating change
Goldman Sachs Maintains Thomson Reuters(TRI.US) With Buy Rating, Raises Target Price to $125Market Newswire · 2026/10/20
-
OnMicro (688790.SH): The company’s satellite communication PA products, which support a tri-mode integration of BeiDou, Tiantong, and low-earth orbit (LEO) systems, have entered mass production.Gelonghui Finance · 2026/11/11
-
Rating change
Jefferies Initiates Thomson Reuters(TRI.US) With Buy Rating, Announces Target Price $130Market Newswire · 2026/10/21
-
Company notice
Icom: Notice of a Basic Agreement on a Strategic Capital and Business Alliance Aimed at Establishing a Joint Venture Between TRI-IDEAS Co., Ltd. and LIMNO Co., Ltd.JPX · 2026/9/30
-
Rating change
BMO Capital Maintains Thomson Reuters(TRI.US) With Buy Rating, Cuts Target Price to $119.11Market Newswire · 2026/8/25
-
Rating change
Analysts Offer Insights on Industrial Goods Companies: Thomson Reuters (TRI), Nano Nuclear Energy Inc. (NNE) and MasTec (MTZ)TipRanks · 2026/8/25
-
Rating change
Barclays Maintains Thomson Reuters(TRI.US) With Buy Rating, Maintains Target Price $140Market Newswire · 2026/8/17
-
Rating change
Goldman Sachs Maintains Thomson Reuters(TRI.US) With Buy Rating, Raises Target Price to $120Market Newswire · 2026/8/6
-
Rating change
A Quick Look at Today's Ratings for Thomson Reuters(TRI.US), With a Forecast Between $100 to $142.71Market Newswire · 2026/8/7
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Thomson Reuters discussion 0 comments